DARPA #DARPA-SN-26-61

DARPA RFI for Hemorrhage Countermeasure Evaluation Capabilities

DARPA's Biological Technologies Office is seeking information on hemorrhage countermeasure evaluation capabilities: - Government Buyer: - Defense Advanced Research Projects Agency (DARPA), Biological Technologies Office - Scope: - Focus on research in biological, health, and synthetic biology fields - Solicitation is a Request for Information (RFI) to gather details on expertise and capabilities - OEMs and Vendors: - No specific Original Equipment Manufacturers (OEMs) or vendors are named - Products/Services Requested: - No specific products, part numbers, or quantities are listed - Respondents are asked to provide information on their capabilities in evaluating hemorrhage countermeasures - Unique Requirements: - Emphasis on research and evaluation capabilities in hemorrhage countermeasures - No additional notable requirements specified

Description

This is a Request for Information (RFI) issued by DARPA's Biological Technologies Office seeking information on capabilities related to hemorrhage countermeasure evaluation. The solicitation focuses on research topics including biological, health, and synthetic biology. The opportunity is open for responses from April 9, 2026, through May 4, 2026. Interested parties are directed to the external SAM.gov link for further details.

View original listing